Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
Deloitte
QuintilesIMS
US Army
Queensland Health
Express Scripts
Colorcon
Teva

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,740,341

« Back to Dashboard

Which drugs does patent 6,740,341 protect, and when does it expire?

Patent 6,740,341 protects ORAPRED ODT and is included in one NDA.

This patent has nine patent family members in seven countries.
Summary for Patent: 6,740,341
Title: Taste masking rapid release coating system
Abstract:The present invention relates to a core containing a drug encased in a spacing layer and a taste masking layer which provides effective taste masking for in-mouth disintegrable dosage forms containing highly objectionable tasting drugs, as well as dosage forms containing these cores.
Inventor(s): Holt; Kris E. (Maple Grove, MN), Khankari; Rajendra K. (Maple Grove, MN), Hontz; John (Plymouth, MN)
Assignee: Cima Labs Inc. (Eden Prairie, MN)
Application Number:09/449,851
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition; Dosage form;

Drugs Protected by US Patent 6,740,341

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-001 Jun 1, 2006 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-002 Jun 1, 2006 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Concordia Pharms Inc ORAPRED ODT prednisolone sodium phosphate TABLET, ORALLY DISINTEGRATING;ORAL 021959-003 Jun 1, 2006 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,740,341

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 753476 ➤ Try a Free Trial
Canada 2351720 ➤ Try a Free Trial
European Patent Office 1133282 ➤ Try a Free Trial
European Patent Office 2260836 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
AstraZeneca
McKinsey
Daiichi Sankyo
Moodys
Johnson and Johnson
Julphar
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.